Sponsored by

Cleveland Clinic Brain Tumor and Neuro-Oncology Center

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 1476 to 1500 of about 5897

Previous 25

Website Changes

05/08/2017

DelMar Presents New Mechanism of Action Data for its Lead Agent VAL-083 in Temozolomide-Resistant Glioblastoma Multiforme (GBM) at the World Federation of Neuro-Oncology Societies (WFNOS)

05/05/2017

Duke researchers develop treatment that triples survival time of brain cancer patients

05/04/2017

Novocure (NVCR) to Open Two Pilot Trials to Evaluate the Use of TTFields for Pediatric

05/04/2017

Research Reveals Non-coding RNA SPRIGHTLY Plays Important Role in Tumour Growth, Spread

05/04/2017

Brain cancer: Study sheds light on unexpected link between glioma and blood sugar

05/02/2017

Using CRISPR to Find Treatments For Aggressive Pediatric Brain Cancers

05/01/2017

Breakthrough brain tumour visualisation drug Gliolan to be listed on NZ hospital medicines list from 1 June

05/01/2017

Musella Foundation Copay Assistance Program reopens!

05/01/2017

Brain Tumor BioTech Conference June 2, 2017 in NY

04/26/2017

TARGETED THERAPY BEING TESTED IN SOCAL GIVES BRAIN CANCER PATIENTS HOPE

04/26/2017

Surgical success in previously “inoperable” brain cancers

04/26/2017

New Tupperware Fundraiser!

04/22/2017

Brains Matter Awareness Fundraiser and Celebration Luncheon / Now Accepting Nomination for our 2017 National Hope Award

04/21/2017

Pediatric Brain Tumor Mutations are Detectable in Cerebrospinal Fluid

04/20/2017

VBL Therapeutics Announces Positive DSMC Review in Phase 3 GLOBE Trial Investigating VB-111 in rGBM

04/19/2017

Effect of gross total resection (GTR) in WHO grade II astrocytomas: A SEER based survival analysis.

04/19/2017

Cloud Over Pediatric Oncologist and Brain Cancer Vaccine

04/18/2017

FDA Okays Clinical Trial of Injectable Brain Cancer Drug - See more at: https://www.specialtypharmacytimes.com/news/fda-okays-clinical-trial-of-injectable-brain-cancer-drug

04/17/2017

CNS Oncology Publishes Data Suggesting Survival Benefit of Optune™ in Combination with Second Line Chemotherapies after Glioblastoma Recurrence

04/17/2017

Survey on the use of animals in brain cancer research

04/14/2017

Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination

04/14/2017

Medicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial

04/12/2017

Feinstein Institute examines use of antiparasitic drug as new treatment for brain tumors

04/09/2017

DFFN: Phase 3 Trial of TSC in GBM to Initiate in 2017

04/07/2017

A Proposed New FDA Drug Approval Pathway: “Conditional Approval”

Our privacy / cookie policy has changed.
Click HERE to read it!